RE: Efficacy against Delta and Omicron17 Dec 2021 09:46
I’m at a loss why Synairgen haven’t reported on Delta, never mind Omicron. Yes, the trial will hopefully have demonstrated effectiveness to Delta but I still don’t see why you wouldn’t report it.
Synairgen, if it is indeed as good as we all hope it is, should be reporting all its findings on the different variants. Again, surely it is duty bound in the current climate to make all relevant parties aware of all and any potential drugs that could help against Covid. I’m led to believe in vitro testing is not a long process, so why the delays?
I can only assume that they want to announce blockbuster P3 results and say at the same time “and here’s our in vitro results on Delta and Omicron that proves it is truly variant agnostic…”. Goodness, that really would get this SP moving.